Literature DB >> 20716531

Peroxisome proliferator-activated receptor {gamma} coactivator 1{alpha} (PGC-1{alpha}) promotes skeletal muscle lipid refueling in vivo by activating de novo lipogenesis and the pentose phosphate pathway.

Serge Summermatter1, Oliver Baum, Gesa Santos, Hans Hoppeler, Christoph Handschin.   

Abstract

Exercise induces a pleiotropic adaptive response in skeletal muscle, largely through peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α). PGC-1α enhances lipid oxidation and thereby provides energy for sustained muscle contraction. Its potential implication in promoting muscle refueling remains unresolved, however. Here, we investigated a possible role of elevated PGC-1α levels in skeletal muscle lipogenesis in vivo and the molecular mechanisms that underlie PGC-1α-mediated de novo lipogenesis. To this end, we studied transgenic mice with physiological overexpression of PGC-1α and human muscle biopsies pre- and post-exercise. We demonstrate that PGC-1α enhances lipogenesis in skeletal muscle through liver X receptor α-dependent activation of the fatty acid synthase (FAS) promoter and by increasing FAS activity. Using chromatin immunoprecipitation, we establish a direct interaction between PGC-1α and the liver X receptor-responsive element in the FAS promoter. Moreover, we show for the first time that increased glucose uptake and activation of the pentose phosphate pathway provide substrates for RNA synthesis and cofactors for de novo lipogenesis. Similarly, we observed increased lipogenesis and lipid levels in human muscle biopsies that were obtained post-exercise. Our findings suggest that PGC-1α coordinates lipogenesis, intramyocellular lipid accumulation, and substrate oxidation in exercised skeletal muscle in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20716531      PMCID: PMC2963391          DOI: 10.1074/jbc.M110.145995

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1.

Authors:  Keith Baar; Adam R Wende; Terry E Jones; Matthew Marison; Lorraine A Nolte; May Chen; Daniel P Kelly; John O Holloszy
Journal:  FASEB J       Date:  2002-12       Impact factor: 5.191

2.  Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells.

Authors:  Julie St-Pierre; Jiandie Lin; Stefan Krauss; Paul T Tarr; Ruojing Yang; Christopher B Newgard; Bruce M Spiegelman
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

3.  Increased intramuscular lipid synthesis and low saturation relate to insulin sensitivity in endurance-trained athletes.

Authors:  Bryan C Bergman; Leigh Perreault; Devon M Hunerdosse; Mary C Koehler; Ali M Samek; Robert H Eckel
Journal:  J Appl Physiol (1985)       Date:  2010-03-18

4.  Incorporation of [6-3H] glucose into lipid, protein, RNA and DNA of slices of differentiating rat cerebral cortex.

Authors:  R I Glazer; G Weber
Journal:  J Neurochem       Date:  1971-08       Impact factor: 5.372

5.  Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes.

Authors:  B H Goodpaster; J He; S Watkins; D E Kelley
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

Review 6.  Molecular basis of skeletal muscle plasticity--from gene to form and function.

Authors:  M Flück; H Hoppeler
Journal:  Rev Physiol Biochem Pharmacol       Date:  2003-01-14       Impact factor: 5.545

7.  Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle.

Authors:  Aaron P Russell; Jonas Feilchenfeldt; Sylvia Schreiber; Manu Praz; Antoinette Crettenand; Charles Gobelet; Christoph A Meier; David R Bell; Anastasia Kralli; Jean-Paul Giacobino; Olivier Dériaz
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

8.  Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres.

Authors:  Jiandie Lin; Hai Wu; Paul T Tarr; Chen-Yu Zhang; Zhidan Wu; Olivier Boss; Laura F Michael; Pere Puigserver; Eiji Isotani; Eric N Olson; Bradford B Lowell; Rhonda Bassel-Duby; Bruce M Spiegelman
Journal:  Nature       Date:  2002-08-15       Impact factor: 49.962

9.  Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes.

Authors:  Luc J C van Loon; René Koopman; Ralph Manders; Walter van der Weegen; Gerrit P van Kranenburg; Hans A Keizer
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-05-27       Impact factor: 4.310

10.  In vivo evaluation of the effects of continuous exercise on skeletal muscle triglycerides in trained humans.

Authors:  J Rico-Sanz; M Moosavi; E L Thomas; J McCarthy; G A Coutts; N Saeed; J D Bell
Journal:  Lipids       Date:  2000-12       Impact factor: 1.880

View more
  46 in total

Review 1.  The diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer.

Authors:  Geoffrey D Girnun
Journal:  Semin Cell Dev Biol       Date:  2012-01-21       Impact factor: 7.727

2.  Skeletal muscle PGC-1α controls whole-body lactate homeostasis through estrogen-related receptor α-dependent activation of LDH B and repression of LDH A.

Authors:  Serge Summermatter; Gesa Santos; Joaquín Pérez-Schindler; Christoph Handschin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

3.  PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis.

Authors:  Kavita Bhalla; Bor Jang Hwang; Ruby E Dewi; Lihui Ou; William Twaddel; Hong-Bin Fang; Scott B Vafai; Francesca Vazquez; Pere Puigserver; Laszlo Boros; Geoffrey D Girnun
Journal:  Cancer Res       Date:  2011-09-13       Impact factor: 12.701

4.  Multiparity leads to obesity and inflammation in mothers and obesity in male offspring.

Authors:  Sandra L Rebholz; Thomas Jones; Katie T Burke; Anja Jaeschke; Patrick Tso; David A D'Alessio; Laura A Woollett
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-11-29       Impact factor: 4.310

Review 5.  Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology.

Authors:  Petra S Eisele; Christoph Handschin
Journal:  Semin Immunopathol       Date:  2013-11-21       Impact factor: 9.623

6.  Muscle-specific activation of Ca(2+)/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice.

Authors:  Hui-Young Lee; Arijeet K Gattu; João-Paulo G Camporez; Shoichi Kanda; Blas Guigni; Mario Kahn; Dongyan Zhang; Thomas Galbo; Andreas L Birkenfeld; Francois R Jornayvaz; Michael J Jurczak; Cheol Soo Choi; Zhen Yan; R Sanders Williams; Gerald I Shulman; Varman T Samuel
Journal:  Diabetologia       Date:  2014-04-11       Impact factor: 10.122

7.  Suppression of 5'-nucleotidase enzymes promotes AMP-activated protein kinase (AMPK) phosphorylation and metabolism in human and mouse skeletal muscle.

Authors:  Sameer S Kulkarni; Håkan K R Karlsson; Ferenc Szekeres; Alexander V Chibalin; Anna Krook; Juleen R Zierath
Journal:  J Biol Chem       Date:  2011-08-26       Impact factor: 5.157

Review 8.  Parkin in the regulation of fat uptake and mitochondrial biology: emerging links in the pathophysiology of Parkinson's disease.

Authors:  Kye-Young Kim; Michael N Sack
Journal:  Curr Opin Lipidol       Date:  2012-06       Impact factor: 4.776

Review 9.  The many roles of PGC-1α in muscle--recent developments.

Authors:  Mun Chun Chan; Zolt Arany
Journal:  Metabolism       Date:  2014-01-17       Impact factor: 8.694

10.  PPARγ coactivator-1α contributes to exercise-induced regulation of intramuscular lipid droplet programming in mice and humans.

Authors:  Timothy R Koves; Lauren M Sparks; J P Kovalik; Merrie Mosedale; Ramamani Arumugam; Karen L DeBalsi; Karen Everingham; Leigh Thorne; Esther Phielix; Ruth C Meex; C Lawrence Kien; Matthijs K C Hesselink; Patrick Schrauwen; Deborah M Muoio
Journal:  J Lipid Res       Date:  2012-11-21       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.